2018 and Beyond: Norway Pharmaceutical and Healthcare Market Trends and Outlook Study to 2025

  • ID: 4590870
  • Report
  • Region: Norway
  • 120 pages
  • VPA Research
1 of 3
Spending on medicines and healthcare in Norway witnessed steady growth in 2017, reflecting strong potential for new medicine development, infrastructure building and new entry/ expansion opportunities. Both Pharmaceutical sales and consumption are on rise and the outlook to 2025 remains robust driven by strong pharmaceutical market fundamentals.

The goal of this report is to provide complete strategic analysis and forecast the pharmaceutical industry segments over the near to long term future.

This report focuses its attention on pharmaceutical market in Norway and presents market trends, drivers and challenges facing the R&D professionals, investors, manufacturers, strategists, regulatory and other players. It also presents the pharmaceutical sales of prescription medicines and generic drugs. Further, pharmaceutical imports and exports data is also provided for the country.

The research study on Norway healthcare spending provides outlook of total spending, government expenditure, private expenditure to 2025. Further, the level of out-of-pocket costs borne by patients is also analyzed.

It additionally explores the level and growth of expenditure on healthcare, new drugs and ongoing research studies. The report also considers the Norway healthcare industry prospects and infrastructure detailing hospitals, physicians, bed count, and other facilities. The report also analyzes the disease epidemiology trends through details of leading causes of death.

Through transparent and consistent methodology, the research work provides meaningful evidence based insights into the industry. Further, objective measures are presented in ready to use format, which enables ease of understanding of Norway pharmaceutical market insights and outlook.
Note: Product cover images may vary from those shown
2 of 3
1.1 List of Tables
1.2 List of Figures

2 Executive Summary
2.1 Norway Pharmaceutical and Healthcare Industry Snapshot
2.2 Norway Pharmaceuticals Market Overview

3 Norway Pharmaceutical Market Strategic Analysis Review
3.1 Pharmaceutical Trends in Norway
3.2 Drivers and Restraints
3.2.1 Market Drivers in Norway Pharmaceuticals and Healthcare Industry
3.2.2 Drivers Explained
3.2.3 Market Restraints in Norway Pharmaceuticals and Healthcare Industry
3.2.4 Restraints Explained

4 Norway Pharmaceutical Market Outlook
4.1 Norway Pharmaceutical Sales, $ Million, 2015- 2025
4.2 Norway Pharmaceutical Exports, $ million, 2015- 2025
4.3 Norway Pharmaceutical Imports, $ Million, 2015- 2025
4.4 Norway (% contribution) to Regional Pharmaceutical Market size, 2017
4.5 Norway (% contribution) to Global Pharmaceutical Market size, 2017
4.6 Norway Prescription Drug Sales, $ Million, 2015- 2025
4.7 Norway Generic Drug Sales, $ Million, 2015- 2025

5 Norway Healthcare Market Outlook
5.1 Norway Healthcare Expenditure Outlook, 2015- 2025
5.2 Norway Healthcare Expenditure (% of GDP), 2015- 2025
5.3 Norway Government Healthcare Expenditure (% of total expenditure), 2015- 2025
5.4 Norway Private Healthcare Expenditure (% of total expenditure), 2015- 2025
5.5 Out of pocket expenditure (% of total expenditure) in Norway, 2015- 2025

6 Norway Healthcare Market Statistics
6.1 Norway Mortality by Disease Category, 2017
6.2 Number of Hospitals in Norway, 2007- 2017
6.3 Number of Hospital Beds in Norway, 2007- 2017
6.4 Physicians Count in Norway, 2007- 2017
6.5 Pharmacists Count in Norway, 2007- 2017

7 Norway Clinical Trials Research Industry
7.1 Total Ongoing Clinical Trials in Norway, 2017
7.2 Ongoing Clinical Trials by Disease Category in Norway, 2017
7.3 Ongoing Clinical Trials by Type, 2017
7.4 Ongoing Clinical Trials by Status, 2017
7.5 Ongoing Clinical Trials by Sponsor Type, 2017

8 Norway Demographic and MacroEconomic Profile
8.1 Norway Population Forecast by Age Group, 2005- 2025
8.2 Norway Population Forecast by Location, 2005- 2025
8.3 Norway GDP Forecast, 2005- 2025
8.4 Norway GDP Per Capita Forecast, 2005- 2025
8.5 Norway Disposable Income Forecast, 2005- 2025

9 Business Profiles of Leading Pharmaceutical Companies
9.1 Johnson and Johnson Pharmaceutical Company Profile
9.2 Bayer Pharmaceutical Company Profile
9.3 Novartis Pharmaceutical Company Profile
9.4 Pfizer Pharmaceutical Company Profile
9.5 Roche Pharmaceutical Company Profile
9.6 Sanofi Pharmaceutical Company Profile
9.7 Merck Pharmaceutical Company Profile
9.8 Gilead Sciences Pharmaceutical Company Profile
9.9 GlaxoSmithKline Pharmaceutical Company Profile
9.10. AstraZeneca Pharmaceutical Company Profile

10 Recent Industry Developments in Norway Pharmaceuticals and Healthcare Markets

11 Appendix
11.1 About the Publisher
11.2 Sources and Methodology
Note: Product cover images may vary from those shown
3 of 3


4 of 3
Note: Product cover images may vary from those shown
Order Online - visit: https://www.researchandmarkets.com/reports/4590870